BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23358729)

  • 1. Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.
    Taliaferro-Smith L; Nagalingam A; Knight BB; Oberlick E; Saxena NK; Sharma D
    Neoplasia; 2013 Jan; 15(1):23-38. PubMed ID: 23358729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
    Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
    Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B.
    Beales ILP; Garcia-Morales C; Ogunwobi OO; Mutungi G
    Mol Cell Endocrinol; 2014 Jan; 382(1):150-158. PubMed ID: 23994026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.
    Sharma D; Wang J; Fu PP; Sharma S; Nagalingam A; Mells J; Handy J; Page AJ; Cohen C; Anania FA; Saxena NK
    Hepatology; 2010 Nov; 52(5):1713-22. PubMed ID: 20941777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.
    Saxena NK; Taliaferro-Smith L; Knight BB; Merlin D; Anania FA; O'Regan RM; Sharma D
    Cancer Res; 2008 Dec; 68(23):9712-22. PubMed ID: 19047149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
    Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
    Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway.
    Yuan HJ; Sun KW; Yu K
    Mol Med Rep; 2014 Jan; 9(1):350-4. PubMed ID: 24213635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration.
    Blanquart C; Karouri SE; Issad T
    Biochem Biophys Res Commun; 2010 Jan; 392(1):83-8. PubMed ID: 20059965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.
    Catalano S; Leggio A; Barone I; De Marco R; Gelsomino L; Campana A; Malivindi R; Panza S; Giordano C; Liguori A; Bonofiglio D; Liguori A; Andò S
    J Cell Mol Med; 2015 May; 19(5):1122-32. PubMed ID: 25721149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.
    Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA
    Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.
    Knight BB; Oprea-Ilies GM; Nagalingam A; Yang L; Cohen C; Saxena NK; Sharma D
    Endocr Relat Cancer; 2011 Aug; 18(4):413-28. PubMed ID: 21555376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.
    Taliaferro-Smith L; Nagalingam A; Zhong D; Zhou W; Saxena NK; Sharma D
    Oncogene; 2009 Jul; 28(29):2621-33. PubMed ID: 19483724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
    Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats.
    Li JM; Li YC; Kong LD; Hu QH
    Hepatology; 2010 May; 51(5):1555-66. PubMed ID: 20222050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis.
    Handy JA; Fu PP; Kumar P; Mells JE; Sharma S; Saxena NK; Anania FA
    Biochem J; 2011 Dec; 440(3):385-95. PubMed ID: 21846328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies?
    Dubois V; Delort L; Billard H; Vasson MP; Caldefie-Chezet F
    PLoS One; 2013; 8(3):e58541. PubMed ID: 23554900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.